Latest news with #MedTech
Time Business News
21 hours ago
- Business
- Time Business News
Innovative Blockchain Solutions Transform Data Security and Patient Care
Blockchain technology in healthcare market offers an unassailable and decentralized digital ledger system that enables healthcare patients, providers, and organizations to transparently and unalterably share medical data. The use of blockchain in healthcare is exploding as it securely manages data, provides enhanced visibility in the supply chain, and can reduce costs by simplifying administrative activities such as billing and claims. Key Growth Drivers and Opportunities Soaring Cyber Attacks on Healthcare Industry: The increase in cyber-attacks aimed to healthcare systems means blockchain can be advanced and adopted as a tool to protect against breaches and ransomware due to the various vulnerabilities in centralized systems. With blockchain, the data is decentralized, encrypted, and immutable. Blockchain gives users the capability to securely share data with specific people and also manages this access via a smart contract. Many companies have used blockchain to promote better record keeping and more security. This more secure and efficient method increases trust in patients and stakeholders, ultimately driving the growth of blockchain within this sector. Challenges Blockchain technologies face hurdles in healthcare such as high costs, complex integration, no standards, and unskilled individuals, which hold back support the overall adoption and scalability of blockchain technologies in the healthcare sector. Innovation and Expansion Arculus, IT Lab, and Circular Protocol Introduce the First Blockchain-Powered Healthcare Provider Ecosystem In March 2025, Circular Protocol has announced a partnership with Arculus by CompoSecure (CMPO) and IT Lab to create the first blockchain-compliant ecosystem for healthcare providers. The initiative focuses on enhancing digital transparency and protection in global healthcare through blockchain technology. The system integrates Arculus Authentication into Circular's MedTech device, providing healthcare facilities with physical cards containing private keys. These cards enable authorized personnel to digitally sign procedures and transactions on the Circular blockchain through a simple tap-to-computer interface. Inventive Sparks, Expanding Markets Key tactics for blockchain technology companies in the healthcare industry include forming strategic partnerships with IT companies and healthcare providers, funding R&D to improve scalability and interoperability, and concentrating on regulatory compliance to protect data privacy. Businesses are also prioritizing the use of AI and IoT technologies, entering emerging markets, and developing specialized blockchain solutions for supply chain management, clinical trials, and patient data protection in order to meet the industry's transformation. VERRA, Patientory Inc., BurstIQ, Chronicled, Guardtime, and others are major companies in the blockchain technology healthcare business. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
Irish Post
4 days ago
- Business
- Irish Post
Minister attends opening of leading Irish medtech firm's new manufacturing facility
A LEADING Irish medtech firm has opened a new state-of-the-art manufacturing facility in Co. Galway to increase production on one of its leading products. Neurent Medical has produced a non-surgical solution for people suffering with chronic rhinitis - a persistent inflammation of the nasal passages, which can cause symptoms such as a runny nose, nasal congestion, and post-nasal drip for more than 12 weeks. Their product Neuromark targets the underlying drivers of the condition so effectively that there is growing demand for the technology both in Ireland and in the US. To meet demand, the firm has launched its new manufacturing site at Westlink Commercial Park in Oranmore. Pictured (l-r) Minister Hildegarde Naughton, Jenny Melia of Enterprise Ireland and Brian Shields, CEO Neurent Medical 'We're proud to scale our operations in Galway, where the MedTech ecosystem continues to thrive,' Neurent Medical CEO Brian Shields said. 'Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland.' He added: 'As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world.' The new facility will bring 125 new highly skilled jobs to the Galway area by the end of 2028, the company has confirmed. The new jobs will range across key functions in engineering, quality control, operations, supply chain management, and sales and marketing. Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of Ireland's medtech success stories. Minister Hildegarde Naughton and Jenny Melia, CEO (Designate) of Enterprise Ireland, who have supported the firm, were at the opening of the new site. 'I want to congratulate Neurent Medical on this significant achievement,' Minister Naighton said. 'Galway is known as a major player in medical technology, being home to eight of the world's top 10 medtech companies. 'As a native myself, I am particularly proud to see 125 new highly skilled jobs being created by a company based in Oranmore,' she added. 'It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. 'I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company.' See More: Enterprise Ireland, Galway, Irish, Medtech, Neurent Medical
Irish Independent
4 days ago
- Business
- Irish Independent
Over 100 jobs set for Galway as leading medical company opens new facility
Located in Westlink Commercial Park, the opening of the new state-of-the-art manufacturing facility marks a 'significant' milestone for the company. The new facility will create 125 new highly skilled jobs by the end of 2028 and will serve as the central hub to produce the company's Neuromark system. The Neuromark system is a minimally invasive medical device designed to target the underlying drivers of chronic rhinitis. The new jobs will range across key functions in engineering, quality control, operations, supply chain management, and sales and marketing. Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of Ireland's MedTech success stories. The official opening event was celebrated with Galway West TD Hildegarde Naughton TD and executive director and incoming CEO of Enterprise Ireland Jenny Melia. Brian Shields, CEO of Neurent Medical, said the company is proud to upgrade its operations in Galway, where the company is headquartered. 'Our new Westlink facility gives us the manufacturing capacity to meet growing demand for NEUROMARK, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland,' he said. 'As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world.' Ms Melia said the announcement of new jobs for the new Oranmore base shows that Ireland is a research and development leader within the medical device space. "Supporting Irish companies with the ambition to scale globally is a key priority for Enterprise Ireland and we will continue to work closely with Brian and the team at Neurent Medical to optimise their full international growth potential, creating and sustaining jobs here in the Galway region," she added. Deputy Naughton noted that Galway is home to eight of the world's top 10 MedTech companies. "It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company," she added.
RTÉ News
4 days ago
- Business
- RTÉ News
Neurent Medical to create 125 jobs in Galway
Healthcare company Neurent Medical is to create 125 new highly skilled jobs in Galway over the next three years. The announcement comes as the company officially opened its new state-of-the-art manufacturing facility at Westlink Commercial Park in Oranmore. The new facility will serve as the central hub for the production of the company's Neuromark system, a treatment option designed to target the underlying drivers of chronic Rhinitis. The new Galway jobs will range across key functions in engineering, quality control, operations, supply chain management, and sales and marketing. Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of the country's MedTech success stories. Since its inception, it said it has leveraged Galway's world-class innovation ecosystem to scale its team, secure FDA regulatory clearances and attract top international clinical collaborators. Brian Shields, CEO of Neurent Medical, said the company was proud to scale its operations in Galway, where the MedTech ecosystem continues to thrive. "Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland," he said. "As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world," he added. Jenny Melia, Executive Director and incoming CEO at Enterprise Ireland, said today's announcement of new jobs based here in Oranmore shows that Ireland is leading in research and development within the medical device space. "Neurent Medical has experienced impressive growth in a short period of time beginning its journey through the BioInnovate Ireland Programme here in Galway with further support awarded through EI's Commercialisation fund programme and through the Disruptive Technologies Innovation Fund administered by Enterprise Ireland for the development of the Neuromark technology," she said. "Supporting Irish companies with the ambition to scale globally is a key priority for Enterprise Ireland and we will continue to work closely with Brian and the team at Neurent Medical to optimise their full international growth potential, creating and sustaining jobs here in the Galway region," she added. Hildegarde Naughton, Minister of State at the Department of Children, Disability and Equality, noted that Galway is home to eight of the world's top 10 MedTech companies. "It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company," she added.
Irish Times
4 days ago
- Business
- Irish Times
Neurent Medical to create 125 jobs at new manufacturing facility in Galway
Galway medtech company Neurent Medical is to create 125 jobs at its new manufacturing facility. The jobs, which will be in engineering, quality control, operations, supply chain, and sales and marketing, will be created by the end of 2028. Neurent Medical has developed a minimally invasive device that helps deal with the inflammatory response that leads to rhinitis, or chronic runny nose. It will be manufactured at the new facility, which was officially opened on Tuesday at Westlink Commercial Park in Oranmore, Co Galway. READ MORE The move follows the recent FDA clearance for the next-generation Neuromark system, which opens the way for further commercialisation in the US. 'We're proud to scale our operations in Galway, where the MedTech ecosystem continues to thrive. Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland,' said Brian Shields, CEO of Neurent Medical. 'As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world.' It also expands the growing medtech ecosystem in Galway. Neurent Medical has its roots in the Enterprise Ireland-supported BioInnovate Ireland Programme, founded by Mr Shields and chief technology officer David Townley as a spin-out, and has grown from concept to commercialisation within a decade. 'Today's announcement of new jobs based here in Oranmore shows that Ireland is leading in research and development within the medical device space,' said chief executive designate of Enterprise Ireland Jenny Melia. 'Supporting Irish companies with the ambition to scale globally is a key priority for Enterprise Ireland and we will continue to work closely with Brian and the team at Neurent Medical to optimise their full international growth potential, creating and sustaining jobs here in the Galway region.' The opening was attended by Minister of State at the Department of Children, Disability and Equalit yHildegarde Naughton. 'Galway is known as a major player in Medical Technology, being home to eight of the world's top 10 MedTech companies,' she said. 'Today's announcement is further evidence of that and, as a native myself, I am particularly proud to see 125 new highly skilled jobs being created by a company based in Oranmore. It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market.'
